Recent papers on solid tumor extend metabolic neuroblastoma

Sorted by publication year (newest first) via OpenAlex. List regenerates every 24h.

  1. Efficacy and safety of standard versus extended interval dosing of PD-1/PD-L1 immune checkpoint inhibitors in solid tumors: A meta-analysis of 4,063 patients.

    2025 · Journal of Clinical Oncology · Patino, J. M. Rodríguez, Rojas, Dolores, Patiño, Brandon Flores et al.

    2025
  2. 2025
  3. Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort

    2023 · European Journal of Cancer · Jonasch, Eric, Bauer, Todd M., Papadopoulos, Kyriakos P. et al.

    2023
  4. Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTEND

    2022 · International Journal of Radiation Oncology*Biology*Physics · Sherry, Alexander D., Bathala, Tharakeswara, Liu, Suyu et al.

    2022
  5. A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors

    2022 · International Immunopharmacology · Morimoto, Kenji, Yamada, Tadaaki, Morimoto, Yoshie et al.

    2022
  6. 208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models

    2020 · Regular and Young Investigator Award Abstracts · Woodall-Jappe, Mary, Chari, Ajai, Namboodiripad, Anil et al.

    2020
  7. The “Fingerprint” of Cancer Extends Beyond Solid Tumor Boundaries: Assessment With a Novel Ultrasound Imaging Approach

    2015 · IEEE Transactions on Biomedical Engineering · Rao, Sneha R., Shelton, Sarah E., Dayton, Paul A.

    2015
  8. Chimeric Antigen Receptor T Cells: Extending Translation from Liquid to Solid Tumors

    2018 · Human Gene Therapy · Morgan, Michael, Schambach, Axel

    2018
  9. Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study

    2018 · Cancer Medicine · Werner, Theresa L., Sachdev, Jasgit C., Swisher, Elizabeth M. et al.

    2018
  10. A Prospective Study of Extending the Implanted Port Heparin Flushing Cycle in Outpatients with Solid Tumors

    2018 · Korean Journal of Adult Nursing · Kim, Hyekyung, Ku, Hyunkyung, Choi, So-eun

    2018
  11. Veliparib (ABT-888) extended-release formulations: A phase 1 study on safety, pharmacokinetics (PK), and bioavailability in patients with advanced solid tumors.

    2016 · Journal of Clinical Oncology · Werner, Theresa L., Sachdev, Jasgit C., Swisher, Elizabeth M. et al.

    2016
  12. Hydrodynamic Tail Vein Injection as a Simple Tool for Yielding Extended Transgene Expression in Solid Tumors

    2016 · Biological and Pharmaceutical Bulletin · Takayama, Takuma, Ukawa, Masami, Kanazawa, Yuki et al.

    2016
  13. Extended linifanib therapy in patients with advanced solid tumors in a phase I trial.

    2010 · Journal of Clinical Oncology · Goh, Brian C., Wong, Chi Hang, Qian, Jiang et al.

    2010
  14. Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors

    2010 · Pediatric Blood & Cancer · McNall‐Knapp, Rene, Williams, Cydni N., Reeves, Elaine N. et al.

    2010
  15. [Value of thoracoscopy in the diagnosis of solid tumors extending into the pleural cavity].

    1983 · PubMed · Jc, Guérin, Biron, E., Jc, Kalb

    1983

Command palette

Jump anywhere, run any action.